Patents Assigned to Silence Therapeutics (London) Ltd.
  • MODIFIED GUIDE RNAS, METHODS AND USES
    Publication number: 20190390195
    Abstract: The present invention discloses modified guide RNAs which can be used with the CRISPR CAS 9 system for modifying gene expression, particularly in mammalian cells for medical or research uses.
    Type: Application
    Filed: October 24, 2016
    Publication date: December 26, 2019
    Applicant: Silence Therapeutics (London) Ltd.
    Inventors: Daniel TONDERA, Jorg KAUFFMAN